Evolution and transmission of drug-resistant tuberculosis in a Russian population

被引:377
作者
Casali, Nicola [1 ]
Nikolayevskyy, Vladyslav [1 ]
Balabanova, Yanina [1 ]
Harris, Simon R. [2 ]
Ignatyeva, Olga [3 ]
Kontsevaya, Irina [3 ]
Corander, Jukka [4 ]
Bryant, Josephine [2 ]
Parkhill, Julian [2 ]
Nejentsev, Sergey [5 ]
Horstmann, Rolf D. [6 ]
Brown, Timothy [1 ]
Drobniewski, Francis [1 ,7 ]
机构
[1] Queen Mary Univ London, Blizard Inst, Clin TB & HIV Grp, Publ Hlth England PHE Natl Mycobacterium Referenc, London, England
[2] Wellcome Trust Sanger Inst, Cambridge, England
[3] Samara Oblast TB Dispensary, Samara, Russia
[4] Univ Helsinki, Dept Math & Stat, Helsinki, Finland
[5] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England
[6] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany
[7] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England
基金
欧洲研究理事会; 英国惠康基金;
关键词
MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; NUCLEOTIDE POLYMORPHISMS; COMPENSATORY MUTATIONS; BEIJING STRAIN; GENE; ETHIONAMIDE; FITNESS; STRATEGIES; KANAMYCIN;
D O I
10.1038/ng.2878
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.
引用
收藏
页码:279 / +
页数:9
相关论文
共 64 条
[1]   Antibiotic resistance and its cost: is it possible to reverse resistance? [J].
Andersson, Dan I. ;
Hughes, Diarmaid .
NATURE REVIEWS MICROBIOLOGY, 2010, 8 (04) :260-271
[2]  
[Anonymous], 2012, Global Tuberculosis Report
[3]  
[Anonymous], 1987, Molecular Evolutionary Genetics, DOI DOI 10.7312/NEI-92038
[4]   Silent nucleotide polymorphisms and a phyogeny for Mycobacterium tuberculosis [J].
Baker, L ;
Brown, T ;
Maiden, MC ;
Drobniewski, F .
EMERGING INFECTIOUS DISEASES, 2004, 10 (09) :1568-1577
[5]   Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy [J].
Balabanova, Y ;
Ruddy, M ;
Hubb, J ;
Yates, M ;
Malomanova, N ;
Fedorin, I ;
Drobniewski, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (02) :136-139
[6]  
Balabanova Y, 2011, BMJ OPEN, V1, DOI [10.1136/bmjopen-2011-000351, 10.1136/bmjopen-2011-0003511]
[7]   Survival of Civilian and Prisoner Drug-Sensitive, Multi- and Extensive Drug- Resistant Tuberculosis Cohorts Prospectively Followed in Russia [J].
Balabanova, Yanina ;
Nikolayevskyy, Vladyslav ;
Ignatyeva, Olga ;
Kontsevaya, Irina ;
Rutterford, Clare M. ;
Shakhmistova, Anastasiya ;
Malomanova, Nadezhda ;
Chinkova, Yulia ;
Mironova, Svetlana ;
Fedorin, Ivan ;
Drobniewski, Francis A. .
PLOS ONE, 2011, 6 (06)
[8]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[9]   Tuberculosis:: drug resistance, fitness, and strategies for global control [J].
Boettger, Erik C. ;
Springer, Burkhard .
EUROPEAN JOURNAL OF PEDIATRICS, 2008, 167 (02) :141-148
[10]   Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis [J].
Borrell, S. ;
Gagneux, S. .
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (06) :815-820